Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM: Correspondence from The New England Journal of Medicine — Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

Comments

Popular posts from this blog

The conflict in Gaza: a view from Israel - The Lancet

George F. Will - Skip the lecture on Israel's 'risks for peace'